Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Philip Home

Newcastle AuthorsTitleYearFull text
Professor Philip Home
Is Insulin Therapy Safe?2020
Professor Philip Home
Cardiovascular outcome trials of glucose-lowering medications: an update2019
Professor Philip Home
Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%2019
Professor Philip Home
Controversies for Glucose Control Targets in Type 2 Diabetes: Exposing the Common Ground2019
Professor Philip Home
Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program2019
Professor Philip Home
The Need for Accuracy in Hemoglobin A1c Proficiency Testing: Why the Proposed CLIA Rule of 2019 Is a Step Backward2019
Professor Philip Home
2020 vision – An overview of prospects for diabetes management and prevention in the next decade2018
Professor Philip Home
A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes2018
Professor Philip Home
Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes2018
Professor Philip Home
Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events2018
1234567891011121314151617181920...